Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients

Cost-Effectiveness and Budget Impact of Hepatitis C Virus Treatment With Sofosbuvir and Ledipasvir in the United States

(2015) Jagpreet Chhatwal et al.   ANNALS OF INTERNAL MEDICINE

Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation

(2015) Catriona Crossan et al.   HEALTH TECHNOLOGY ASSESSMENT

Reversal, maintenance or progression: What happens to the liver after a virologic cure of hepatitis C?

(2014) Youngmin A. Lee et al.   ANTIVIRAL RESEARCH

Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C

(2014) Ramón San Miguel et al.   GUT

Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation

(2014) M Stevenson et al.   HEALTH TECHNOLOGY ASSESSMENT

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

(2014) Kris V. Kowdley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ultrasound Elastography for Fibrosis Surveillance Is Cost Effective in Patients with Chronic Hepatitis C Virus in the UK

(2013) C. Canavan et al.   DIGESTIVE DISEASES AND SCIENCES

Non-Invasive Diagnostic and Prognostic Evaluation of Liver Cirrhosis and Portal Hypertension

(2013) Annalisa Berzigotti et al.   DISEASE MARKERS

ARFI, FibroScan®, ELF, and their combinations in the assessment of liver fibrosis: A prospective study

(2012) Gonzalo Crespo et al.   JOURNAL OF HEPATOLOGY

Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis - A randomized open-label controlled study

(2012) Moon Young Kim et al.   LIVER INTERNATIONAL

Long-term Clinical Course of Decompensated Alcoholic Cirrhosis

(2011) Marco Antonio Alvarez et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Structural Frameworks and Key Model Parameters in Cost-Effectiveness Analyses for Current and Future Treatments of Chronic Hepatitis C

(2011) Rebecca Townsend et al.   VALUE IN HEALTH

Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C

(2010) S. M. Martinez et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Noninvasive assessment of liver fibrosis

(2010) Stella M. Martínez et al.   HEPATOLOGY

Clinical course of alcoholic liver cirrhosis: A Danish population-based cohort study

(2009) Peter Jepsen et al.   HEPATOLOGY

Influence of Liver Biopsy on Abstinence in Alcohol-Dependent Patients

(2008) J.-B. Trabut et al.   ALCOHOL AND ALCOHOLISM

Exceeding the limits of liver histology markers

(2008) Shruti H. Mehta et al.   JOURNAL OF HEPATOLOGY

Assessing liver fibrosis

(2008) Laurent Castera   Expert Review of Gastroenterology & Hepatology